Edit
Ahammune Biosciences Pvt. Ltd.
https://www.ahammune.com/Last activity: 24.01.2025
Probably Closed
Ahammune Biosciences Pvt. Ltd. is a startup company based in Pune. Ahammune Biosciences is an innovation-led drug discovery company started in 2016 which focuses on developing new treatment options for immune mediated diseases of the skin. Our current program is on the depigmenting disorder, Vitiligo. The current treatments for Vitiligo provide only temporary and symptomatic relief. Thus, there is an enormous unmet global need in treating patients with Vitiligo. The mission of Ahammune Biosciences is to arrest the progress of Vitiligo and to induce re-pigmentation of depigmented patches. We are committed to take our innovation-driven drug discovery platform to the next level to demonstrate to the world that we as a nation can foster new molecules for complex diseases.
Location: India, Maharashtra, Pune
Employees: 1-10
Total raised: $5M
Founded date: 2016
Investors 1
| Date | Name | Website |
| - | Indian Ang... | iangroup.v... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.09.2024 | Series A | $5M | - |
Mentions in press and media 11
| Date | Title | Description |
| 24.01.2025 | Kotak Alternate Asset Managers Marks First Close of INR 1,600 Cr Life Sciences Fund The fund aims to target early- to growth-stage companies across pharmaceuticals, biotechnology, medical devices, dig... | Kotak Alternate Asset Managers Ltd, a subsidiary of Kotak Mahindra Group, announced the first close of its Kotak Life Sciences Fund, a private equity vehicle aimed at India's healthcare and life sciences sector. The fund, sized at INR 1,600... |
| 28.09.2024 | [Weekly funding roundup Sept 21-27] VC inflow continues to show strong traction Recommended Stories For You | Venture capital funding into Indian startups continues to remain high given the inflow of large-value deals in September. The last week of the month saw total funding reach $430 million spread across 24 deals. In contrast, the previous week... |
| 26.09.2024 | Biotech startup Ahammune Biosciences raised $5 M Series A funding from pi Ventures | $5 million was raised in a Series A funding round led by pi Ventures for the biotech startup Ahammune Biosciences. Along with current investors Ideaspring Capital, Kotak Alternate Assets, Legacy Assets LLP, and IAN, the round also saw parti... |
| 25.09.2024 | India's Ahammune Biosciences snags $5m round led by deep tech investor pi Ventures | Ahammune Biosciences, an Indian clinical-stage therapeutics company working on new ways to cure skin diseases, on Wednesday, said it has raised $5 million in a Series A round of funding led by early-stage deep tech-focused investor pi Ventu... |
| 25.09.2024 | Ahammune Biosciences raises $5 million to fund novel vitiligo therapy | ETtech Pune-based Ahammune Biosciences, a clinical stage therapeutics company working towards creating new ways to treat and cure skin diseases, has raised a Series A funding round of $5 million led by pi Ventures. Read More News on Ahammun... |
| 25.09.2024 | Ahammune Biosciences Raises $5 Mn To Speed Up Drug Development For Vitiligo | SUMMARY The funding round was led by pi Ventures and also saw participation from Capital2B, Colossa Ventures, Bipin Agarwal, Unicornus Maximus, Ideaspring Capital, among others Ahammune Biosciences is a clinical-stage therapeutics startup w... |
| 25.09.2024 | Ahammune Biosciences bags $5M in Series A funding Recommended Stories For You | Ahammune Biosciences has raised $5 million in a Series A funding round led by early-stage venture fund, pi Ventures. The fundraise also saw participation from Capital2B, Colossa Ventures, Bipin Agarwal, Unicornus Maximus LLP, and existing i... |
| 25.09.2024 | AI cloud startup Aarna.ml raises $6.7M in Series A round Recommended Stories For You | Aarna.ml, a provider of open-source GPU-as-a-Service (GPUaaS) AI cloud software, on Wednesday, said it raised $6.7 million in a Series A funding round led by Exfinity Venture Partners. The Bengaluru startup will use the capital to accelerat... |
| 25.09.2024 | Biotech Startup Ahammune Biosciences Raises $5 Million in Series A Funding The fresh funds will be used to support Phase II human clinical trials | Ahammune Biosciences, a clinical-stage therapeutics company focused on developing new treatments for skin diseases, has raised USD 5 million in Series A funding. The round was led by pi Ventures, with participation from Capital2B, Colossa V... |
| 21.03.2021 | The Winners Of The TiE Women Global Pitch Competition Share Their Thoughts On Building A More Equitable Startup Ecosystem | March 21, 2021 9 min read Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur Middle East, an international franchise of Entrepreneur Media. Does anyone else feel like the world seems to be following t... |
Show more